Meiji Seika Pharma
「Meiji Seika Pharma」熱門搜尋資訊
Pharmaceuticals
https://www.meiji.com
Beginning with the production of penicillin in 1946, Meiji Seika Pharma has established itself as a leader in the manufacture and sale of antibacterial drugs.
Meiji Seika ファルマ株式会社 明治グループの薬品会社
https://www.meiji-seika-pharma
明治グループの医薬品事業会社、Meiji Seika ファルマの公式サイトです。ワクチンによる予防から抗菌薬による治療まで感染症領域を重点基盤とし、新薬開発や ...
Pipeline
https://www.meiji.com
Meiji Seika Pharma Co., Ltd. Based in Japan, we are a leading developer and manufacturer of antibacterial drugs, vaccines and biotech solutions, with a ...
Meiji Seika Pharma 目標2026年營收達到2740億日圓
https://tpatw.org.tw
根據公司的預測，2026年營收將達到2,740億日元（約新台幣564億元），相較於2023年增加590億日元（約新台幣122億元），營業利潤將達到400億日元（約新台幣83億元）， ...
Meiji Seika Pharma
https://en.wikipedia.org
It markets treatments for depression, obsessive-compulsive disorder, vaccines and allergy drugs. Meiji Pharma is doing research in generic anticancer drugs and ...
搜尋條件Meiji Seika Pharma Co.
https://www1.cde.org.tw
搜尋條件Meiji Seika Pharma Co., Ltd. ，搜尋結果清單如下，共搜尋到1筆資料：. No. 1 執行狀態：進行中 試驗藥品名稱/ 成分： Nacubactam / Nacubactam. 試驗計畫標題 ...
Meiji Seika Pharma Co.
https://www.jpma.or.jp
Meiji Seika Pharma Co., Ltd. Address. 2-4-16 Kyobashi, Chuo-ku, Tokyo 104-8002. Contact. Phone：+81-3-3273-6030. FAX：+81-3-3281-7046. Homepage.
Meiji Seika Pharma Co.
https://www.amrindustryallianc
Meiji Seika Pharma Co., Ltd., Japan. 4-16 Kyobashi 2-chome, Chuo-ku, Tokyo 104-8002, Japan. Website. stay informed. Subscribe to receive our updates.
The World's First Approved Vaccine Applying Self
https://www.meiji-seika-pharma
Meiji Seika Pharma obtained exclusive rights to distribute Kostaive™ (ARCT-154)_ in Japan from CSL Seqirus on April 11, 2023, and is ...